000 01454 a2200421 4500
005 20250513202406.0
264 0 _c20040120
008 200401s 0 0 eng d
022 _a0940-5429
024 7 _a10.1007/s005920050159
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSimpson, A J
245 0 0 _aCirculating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study.
_h[electronic resource]
260 _bActa diabetologica
_cSep 1999
300 _a155-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aDiabetes Mellitus, Type 1
_xblood
650 0 4 _aDiabetic Retinopathy
_xblood
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aFibrinolysis
_xphysiology
650 0 4 _aGlycated Hemoglobin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPilot Projects
650 0 4 _aPlasminogen Activator Inhibitor 1
_xblood
650 0 4 _aPlatelet Count
650 0 4 _aRetinal Neovascularization
_xmetabolism
650 0 4 _aTissue Plasminogen Activator
_xblood
700 1 _aBooth, N A
700 1 _aMoore, N R
700 1 _aLewis, S J
700 1 _aGray, R S
773 0 _tActa diabetologica
_gvol. 36
_gno. 3
_gp. 155-8
856 4 0 _uhttps://doi.org/10.1007/s005920050159
_zAvailable from publisher's website
999 _c10618796
_d10618796